Flatiron Health: Real-World Evidence Transforming Oncology

Revolutionizing Oncology Through Data-Driven Healthcare Technology

The intersection of technology and healthcare continues to expand as organizations recognize the transformative potential of data science and clinical innovation. Flatiron Health stands at the forefront of this movement, operating as a specialized healthtech enterprise dedicated to enhancing cancer care delivery across medical institutions worldwide. Founded in 2012 and later acquired by Roche in 2018, Flatiron Health has evolved into a global organization with over 2,500 employees distributed across major markets including the United States, United Kingdom, Germany, and Japan, with its primary headquarters located in New York City.

The organization’s fundamental purpose centers on bridging the gap between patient care experiences and actionable research insights. By synthesizing clinical information and data analytics, Flatiron Health transforms raw patient data into evidence-based intelligence that informs treatment protocols, influences policy decisions, and accelerates medical research initiatives. This commitment to leveraging real-world evidence represents a paradigm shift in how healthcare organizations approach both individual patient outcomes and broader epidemiological understanding.

Understanding the Core Mission and Impact

Flatiron Health operates with a clear vision: to construct an infrastructure where technological advancement and scientific rigor eliminate the historical separation between clinical practice and research exploration. The organization achieves this through a multifaceted approach that touches nearly every stakeholder in the cancer care ecosystem. Rather than operating in isolation, Flatiron collaborates with pharmaceutical companies, academic research institutions, cancer treatment centers, and regulatory bodies to ensure that the evidence generated serves practical and strategic purposes.

One of the most significant contributions Flatiron makes to the healthcare landscape is its ability to generate real-world evidence through access to comprehensive oncological datasets. The organization maintains sophisticated repositories containing information from over five million de-identified patient records, encompassing more than 1.5 billion individual data points. These datasets span 22 different tumor types across four of the world’s largest oncology markets, providing researchers and pharmaceutical developers with unprecedented insight into how cancer treatments perform in actual clinical settings rather than solely within controlled trial environments.

Advanced Technology Infrastructure and Data Solutions

The technological backbone enabling Flatiron’s mission involves proprietary systems and methodologies developed over years of specialization in oncology informatics. The organization’s Horizon platform represents the cornerstone of its evidence generation capabilities, seamlessly integrating vast amounts of labeled oncology data with machine learning algorithms specifically trained on disease-specific patterns. This integration allows researchers to navigate complex patient journeys with unprecedented speed and accuracy.

Beyond data aggregation, Flatiron has developed Clinical Pipe, an innovative electronic health record-to-electronic data capture connector that revolutionizes how clinical study data flows between systems. This tool significantly reduces administrative burdens associated with manual data entry and monitoring queries, allowing research teams to concentrate their efforts on discovery and insight generation rather than data management logistics. The system operates within strict compliance frameworks, adhering to SOC-2 standards, HITRUST certification, HIPAA regulations, GDPR requirements, and FDA’s 21 CFR 11 standards, ensuring that sensitive patient information remains protected throughout processing and analysis.

These technological achievements represent more than software engineering; they embody a deep understanding of oncology workflows, regulatory requirements, and the practical challenges faced by cancer centers attempting to contribute meaningfully to medical research while maintaining operational excellence in patient care.

Solutions Tailored Across the Drug Development Lifecycle

Flatiron’s Evidence Solutions portfolio addresses distinct needs at various stages of pharmaceutical development and commercialization. During early research phases, companies leverage Flatiron’s datasets to refine target product profiles, understanding which patient populations might benefit most from investigational therapies based on real-world treatment patterns and outcomes. This early-stage application of real-world evidence can significantly accelerate decisions about which therapeutic directions merit substantial investment.

As treatments progress through development, pharmaceutical companies utilize Flatiron’s comparative effectiveness research capabilities to contextualize performance against existing standard-of-care options. Rather than relying exclusively on trial data that may not reflect typical patient populations, companies gain insight into how their candidates perform when adopted in diverse clinical settings. This intelligence proves invaluable during regulatory submissions, where demonstrating superiority or equivalence to existing therapies represents a critical requirement for approval consideration.

Upon commercialization, Flatiron’s ongoing real-world evidence generation continues supporting market access and health technology assessment processes. Having collaborated with regulatory agencies and health technology assessment bodies for over five years, Flatiron understands the specific evidence frameworks and analytical rigor demanded by organizations determining drug coverage and reimbursement policies. This expertise translates into solutions specifically designed to address the questions these influential stakeholders pose about cost-effectiveness, safety profiles in diverse populations, and treatment outcomes across different clinical scenarios.

Workplace Culture and Professional Development Environment

Beyond its technological and scientific contributions, Flatiron Health has cultivated a distinctive workplace culture designed to attract and retain talented professionals committed to healthcare innovation. The organization maintains hybrid-flexible work arrangements with employees typically expected in office settings approximately three days weekly, allowing teams to balance collaborative in-office work with the productivity benefits of remote flexibility.

The company’s commitment to employee wellness extends across multiple dimensions of professional and personal life. Comprehensive health benefits encompassing medical, dental, and vision coverage form the foundation, supplemented by mental well-being tools and services recognizing that healthcare professionals face unique occupational stressors. Financial wellness support includes dedicated advisors helping employees navigate retirement planning, investment strategies, and financial literacy, while 401(k) matching programs reinforce organizational commitment to long-term employee prosperity.

Family-supportive policies distinguish Flatiron’s approach to workplace benefits. The organization provides generous parental leave, fertility support programs, adoption assistance, and surrogacy coverage, recognizing that employees at different life stages require tailored support structures. Backup dependent care services address childcare challenges, while flexible paid time-off policies and work-life autonomy enable employees to manage personal obligations without administrative friction.

Fostering Inclusion Through Employee Resource Groups

Recognizing that diverse perspectives strengthen organizational problem-solving and innovation capacity, Flatiron has established a comprehensive network of Employee Resource Groups (ERGs) designed to build community among employees from underrepresented backgrounds while advancing organizational inclusion initiatives.

The organization maintains multiple ERGs addressing various dimensions of identity and experience:

• Women at Flatiron focuses on building trusted community spaces responsive to women’s professional experiences and advancement within the organization
• Blackiron facilitates professional development and leadership opportunities specifically for Black employees while extending programming to the broader community
• Desi creates community among employees with South Asian heritage spanning India, Pakistan, Afghanistan, Bangladesh, Sri Lanka, Nepal, Bhutan, and the Maldives
• Shalom celebrates and supports Jewish employees through cultural programming and community connection
• AccessAbility advocates for disabled employees and populations served by Flatiron, raising awareness about accessibility barriers
• Next Generation provides parenting support and resources for employees navigating parenthood alongside professional responsibilities
• VelvetMafia builds community celebrating LGBTQ+ identities and supporting queer employees across the organization
• Amig@sLatin@s creates inclusive space for Latino/a/e/x and Hispanic employees, acknowledging community diversity and cultural connectedness
• API@Flatiron fosters community for Asian and Pacific Islander employees while supporting organizations addressing issues within these communities
• Mubarak facilitates inclusion for employees of Middle Eastern, North African, and Southwest Asian descent

Professional Development and Innovation Pathways

Flatiron demonstrates commitment to employee growth through comprehensive professional development programming. Structured onboarding processes ensure new hires understand organizational mission and quickly integrate into team environments. Mentoring and coaching programs pair employees with more experienced colleagues, facilitating knowledge transfer and accelerating professional maturation.

Leadership development receives particular emphasis, with manager training and leadership development programs preparing high-potential employees for expanded responsibilities. Flatiron University provides technical skill development encompassing coding languages, presentation techniques, and meeting facilitation—recognition that effective innovation requires diverse skill sets beyond domain expertise.

The organization’s quarterly Hackathons represent distinctive innovation engines, providing employees across functions opportunity to collaborate on novel solutions to organizational challenges. These events foster cross-functional relationships while channeling creative energy toward tangible outcomes that strengthen organizational capabilities.

Global Expansion and Network Development

Flatiron’s international presence reflects growing recognition that cancer care challenges transcend geographic boundaries and that evidence generated in diverse healthcare systems enriches comparative understanding. Operating office hubs strategically positioned across major global markets, the organization builds collaborative networks connecting changemakers across continental divides. These hybrid workspaces are designed intentionally to facilitate innovation regardless of physical location, leveraging technology to create virtual continuity within distributed teams.

The organization’s growth trajectory and geographic expansion signal investor confidence in the healthtech model and market recognition of real-world evidence’s increasing importance in pharmaceutical development and healthcare policy formulation.

Looking Forward: Evolution of Healthcare Evidence

As healthcare systems increasingly emphasize value-based care and outcomes transparency, organizations like Flatiron Health occupy increasingly central positions in determining how treatments are evaluated, compared, and ultimately adopted. The combination of sophisticated technology infrastructure, expansive datasets, regulatory expertise, and workplace culture designed to attract top talent positions Flatiron advantageously for continued innovation in oncology evidence generation.

For professionals considering careers in healthcare technology, Flatiron represents an opportunity to contribute meaningfully to cancer care advancement while working within an organizational culture that values both innovation and employee well-being. The organization’s commitment to diversity, professional development, and mission-driven work creates an environment where technical excellence and human-centered values reinforce one another, ultimately translating into better cancer care outcomes for patients worldwide.

Frequently Asked Questions

Q: What exactly does Flatiron Health do?

A: Flatiron Health is a healthtech company that generates real-world evidence from cancer treatment data to improve patient care, accelerate drug development, inform healthcare policy, and advance medical research. The organization transforms patient experiences and clinical information into actionable insights that benefit multiple stakeholders across the healthcare ecosystem.

Q: How much patient data does Flatiron maintain?

A: Flatiron maintains de-identified records for over five million patients containing more than 1.5 billion individual data points spanning 22 different tumor types across four major global oncology markets. This comprehensive dataset represents one of the world’s richest sources of real-world oncology information.

Q: Where does Flatiron Health operate?

A: Flatiron Health is headquartered in New York City and operates office locations across the United Kingdom, Germany, Japan, and the United States, with over 2,500 employees distributed globally. The organization maintains hybrid-friendly workspaces designed to facilitate collaboration among distributed teams.

Q: What types of benefits does Flatiron offer employees?

A: Flatiron provides comprehensive benefits including medical, dental, and vision coverage; mental health support; flexible work arrangements; generous parental leave and family support; financial wellness resources; professional development programming; and a robust network of Employee Resource Groups supporting diverse employee communities.

Q: How is patient privacy protected within Flatiron’s systems?

A: Flatiron maintains strict compliance with SOC-2 standards, HITRUST certification, HIPAA regulations, GDPR requirements, and FDA’s 21 CFR 11 standards. All patient data is de-identified and encrypted during transfer and storage, ensuring sensitive information remains protected throughout processing and analysis.

Q: How does Flatiron work with pharmaceutical companies?

A: Flatiron provides tailored real-world evidence solutions supporting pharmaceutical companies across the drug development lifecycle, from early research through commercialization. Services include target product profile refinement, comparative effectiveness research, regulatory submission support, and health technology assessment preparation.

Written by

Medha Deb

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts. Medha specializes in the areas of beauty, health, sports, and wellness and is committed to ensuring that the content on the website is…